Skip to main content
Top
Published in: Reviews in Endocrine and Metabolic Disorders 1/2007

01-03-2007

The neuroendocrine physiology of kisspeptin in the human

Authors: Waljit S Dhillo, Kevin G Murphy, Stephen R Bloom

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 1/2007

Login to get access

Abstract

Kisspeptin is a 54-amino acid peptide, encoded by the KiSS-1 gene, which activates the G protein-coupled receptor GPR54. Recent evidence suggests the kisspeptin/GPR54 system is a key regulator of reproduction. GPR54-deficient mice have abnormal sexual development. Central or peripheral administration of kisspeptin stimulates the hypothalamic-pituitary-gonadal (HPG) axis in animal models. This review discusses the evidence that kisspeptin also plays a key role in human reproduction. Inactivating GPR54 mutations cause normosmic hypogonadotrophic hypogonadism in humans. Mutations which increase GPR54 signaling are associated with gonadotrophin-dependant premature puberty. Acute intravenous administration of kisspeptin to healthy human male volunteers potently increased plasma LH levels and significantly increased plasma FSH and testosterone without side effects. Plasma kisspeptin is found at low concentrations in the circulation of men and non-pregnant women, but is markedly increased in pregnancy. The placenta is believed to be the source of these high levels of circulating kisspeptin. The kisspeptin-GPR54 system is also implicated in tumour biology. Consistent with this role, plasma kisspeptin concentrations are elevated in patients with abnormal proliferation of placental tissue (gestational trophoblastic neoplasia or GTN) at presentation and fall after treatment with chemotherapy. The kisspeptin/GPR54 system therefore appears to play an important role in the regulation of reproduction in humans. Kisspeptin represents a novel tool for the manipulation of the HPG axis in humans and plasma kisspeptin may be a novel tumour marker in patients with GTN.
Literature
1.
go back to reference Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden JM, Le PE, et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem 2001;276(37):34631–6.PubMedCrossRef Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden JM, Le PE, et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem 2001;276(37):34631–6.PubMedCrossRef
2.
go back to reference Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 1996;88(23):1731–7.PubMedCrossRef Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 1996;88(23):1731–7.PubMedCrossRef
3.
go back to reference de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A 2003;100(19):10972–6.PubMedCrossRef de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A 2003;100(19):10972–6.PubMedCrossRef
4.
go back to reference Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS, Jr., Shagoury JK, et al. The GPR54 gene as a regulator of puberty. N Engl J Med 2003;349(17):1614–27.PubMedCrossRef Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS, Jr., Shagoury JK, et al. The GPR54 gene as a regulator of puberty. N Engl J Med 2003;349(17):1614–27.PubMedCrossRef
5.
go back to reference Funes S, Hedrick JA, Vassileva G, Markowitz L, Abbondanzo S, Golovko A, et al. The KiSS-1 receptor GPR54 is essential for the development of the murine reproductive system. Biochem Biophys Res Commun 2003;312(4):1357–63.PubMedCrossRef Funes S, Hedrick JA, Vassileva G, Markowitz L, Abbondanzo S, Golovko A, et al. The KiSS-1 receptor GPR54 is essential for the development of the murine reproductive system. Biochem Biophys Res Commun 2003;312(4):1357–63.PubMedCrossRef
6.
go back to reference Smith JT, Clifton DK, Steiner RA. Regulation of the neuroendocrine reproductive axis by kisspeptin-GPR54 signaling. Reproduction 2006;131(4):623–30.PubMedCrossRef Smith JT, Clifton DK, Steiner RA. Regulation of the neuroendocrine reproductive axis by kisspeptin-GPR54 signaling. Reproduction 2006;131(4):623–30.PubMedCrossRef
7.
go back to reference Pallais JC, Bo-Abbas Y, Pitteloud N, Crowley WF, Jr., Seminara SB. Neuroendocrine, gonadal, placental, and obstetric phenotypes in patients with IHH and mutations in the G-protein coupled receptor, GPR54. Mol Cell Endocrinol 2006;254–255:70–7.PubMedCrossRef Pallais JC, Bo-Abbas Y, Pitteloud N, Crowley WF, Jr., Seminara SB. Neuroendocrine, gonadal, placental, and obstetric phenotypes in patients with IHH and mutations in the G-protein coupled receptor, GPR54. Mol Cell Endocrinol 2006;254–255:70–7.PubMedCrossRef
8.
go back to reference Semple RK, Achermann JC, Ellery J, Farooqi IS, Karet FE, Stanhope RG, et al. Two novel missense mutations in g protein-coupled receptor 54 in a patient with hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2005;90(3):1849–55.PubMedCrossRef Semple RK, Achermann JC, Ellery J, Farooqi IS, Karet FE, Stanhope RG, et al. Two novel missense mutations in g protein-coupled receptor 54 in a patient with hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2005;90(3):1849–55.PubMedCrossRef
9.
go back to reference Lanfranco F, Gromoll J, von ES, Herding EM, Nieschlag E, Simoni M. Role of sequence variations of the GnRH receptor and G protein-coupled receptor 54 gene in male idiopathic hypogonadotropic hypogonadism. Eur J Endocrinol 2005;153(6):845–52.PubMedCrossRef Lanfranco F, Gromoll J, von ES, Herding EM, Nieschlag E, Simoni M. Role of sequence variations of the GnRH receptor and G protein-coupled receptor 54 gene in male idiopathic hypogonadotropic hypogonadism. Eur J Endocrinol 2005;153(6):845–52.PubMedCrossRef
10.
go back to reference Teles M, Bianco SZ, Brito VN, Trarbach E, Seminara SB, Arnhold IJ, et al. An activating mutation in GPR54 gene causes gonadotrophin-dependent precocious puberty. American Endocrine Society Meeting, Boston, USA, 2006. OR34–3. Teles M, Bianco SZ, Brito VN, Trarbach E, Seminara SB, Arnhold IJ, et al. An activating mutation in GPR54 gene causes gonadotrophin-dependent precocious puberty. American Endocrine Society Meeting, Boston, USA, 2006. OR34–3.
11.
go back to reference Dhillo WS, Chaudhri OB, Patterson M, Thompson EL, Murphy KG, Badman MK, et al. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab 2005;90(12):6609–15.PubMedCrossRef Dhillo WS, Chaudhri OB, Patterson M, Thompson EL, Murphy KG, Badman MK, et al. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab 2005;90(12):6609–15.PubMedCrossRef
12.
go back to reference Matsui H, Takatsu Y, Kumano S, Matsumoto H, Ohtaki T. Peripheral administration of metastin induces marked gonadotropin release and ovulation in the rat. Biochem Biophys Res Commun 2004; 320(2):383–8.PubMedCrossRef Matsui H, Takatsu Y, Kumano S, Matsumoto H, Ohtaki T. Peripheral administration of metastin induces marked gonadotropin release and ovulation in the rat. Biochem Biophys Res Commun 2004; 320(2):383–8.PubMedCrossRef
13.
go back to reference Thompson EL, Murphy KG, Patterson M, Bewick GA, Stamp GW, Curtis AE, et al. Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats. Am J Physiol Endocrinol Metab 2006;291(5):E1074–82.PubMedCrossRef Thompson EL, Murphy KG, Patterson M, Bewick GA, Stamp GW, Curtis AE, et al. Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats. Am J Physiol Endocrinol Metab 2006;291(5):E1074–82.PubMedCrossRef
14.
go back to reference Navarro VM, Castellano JM, Fernandez-Fernandez R, Tovar S, Roa J, Mayen A, et al. Effects of KiSS-1 peptide, the natural ligand of GPR54, on follicle-stimulating hormone secretion in the rat. Endocrinology 2005;146(4):1689–97.PubMedCrossRef Navarro VM, Castellano JM, Fernandez-Fernandez R, Tovar S, Roa J, Mayen A, et al. Effects of KiSS-1 peptide, the natural ligand of GPR54, on follicle-stimulating hormone secretion in the rat. Endocrinology 2005;146(4):1689–97.PubMedCrossRef
15.
go back to reference Mead EJ, Maguire JJ, Kuc RE, Davenport AP. Kisspeptins are novel potent vasoconstrictors in humans, with a discrete localization of their receptor GPR54, to atherosclerosis prone vessels. Endocrinology 2007;148(1):140–7.PubMedCrossRef Mead EJ, Maguire JJ, Kuc RE, Davenport AP. Kisspeptins are novel potent vasoconstrictors in humans, with a discrete localization of their receptor GPR54, to atherosclerosis prone vessels. Endocrinology 2007;148(1):140–7.PubMedCrossRef
16.
go back to reference Seminara SB, Dipietro MJ, Ramaswamy S, Crowley WF, Jr., Plant TM. Continuous human metastin 45–54 infusion desensitizes G protein-coupled receptor 54-induced gonadotropin-releasing hormone release monitored indirectly in the juvenile male Rhesus monkey (Macaca mulatta): a finding with therapeutic implications. Endocrinology 2006;147(5):2122–6.PubMedCrossRef Seminara SB, Dipietro MJ, Ramaswamy S, Crowley WF, Jr., Plant TM. Continuous human metastin 45–54 infusion desensitizes G protein-coupled receptor 54-induced gonadotropin-releasing hormone release monitored indirectly in the juvenile male Rhesus monkey (Macaca mulatta): a finding with therapeutic implications. Endocrinology 2006;147(5):2122–6.PubMedCrossRef
17.
go back to reference Wollesen F, Swerdloff RS, Odell WD. LH and FSH responses to luteinizing-releasing hormone in normal, adult, human males. Metabolism 1976;25(8):845–63.PubMedCrossRef Wollesen F, Swerdloff RS, Odell WD. LH and FSH responses to luteinizing-releasing hormone in normal, adult, human males. Metabolism 1976;25(8):845–63.PubMedCrossRef
18.
go back to reference Hudson RW, Crawford VA, McKay DE. The gonadotropin response of men with varicoceles to a four-hour infusion of gonadotropin-releasing hormone. Fertil Steril 1981;36(5):633–7.PubMed Hudson RW, Crawford VA, McKay DE. The gonadotropin response of men with varicoceles to a four-hour infusion of gonadotropin-releasing hormone. Fertil Steril 1981;36(5):633–7.PubMed
19.
go back to reference Fauser BC, Dony JM, Doesburg WH, Rolland R. The effect of pulsatile and continuous intravenous luteinizing hormone-releasing hormone administration on pituitary luteinizing hormone and follicle-stimulating hormone release in normal men. Fertil Steril 1983;39(5):695–9.PubMed Fauser BC, Dony JM, Doesburg WH, Rolland R. The effect of pulsatile and continuous intravenous luteinizing hormone-releasing hormone administration on pituitary luteinizing hormone and follicle-stimulating hormone release in normal men. Fertil Steril 1983;39(5):695–9.PubMed
20.
go back to reference Smith JT, Acohido BV, Clifton DK, Steiner RA. KiSS-1 neurones are direct targets for leptin in the ob/ob mouse. J Neuroendocrinol 2006;18(4):298–303.PubMedCrossRef Smith JT, Acohido BV, Clifton DK, Steiner RA. KiSS-1 neurones are direct targets for leptin in the ob/ob mouse. J Neuroendocrinol 2006;18(4):298–303.PubMedCrossRef
21.
go back to reference Castellano JM, Navarro VM, Fernandez-Fernandez R, Nogueiras R, Tovar S, Roa J, et al. Changes in hypothalamic KiSS-1 system and restoration of pubertal activation of the reproductive axis by kisspeptin in undernutrition. Endocrinology 2005;146(9):3917–25.PubMedCrossRef Castellano JM, Navarro VM, Fernandez-Fernandez R, Nogueiras R, Tovar S, Roa J, et al. Changes in hypothalamic KiSS-1 system and restoration of pubertal activation of the reproductive axis by kisspeptin in undernutrition. Endocrinology 2005;146(9):3917–25.PubMedCrossRef
22.
go back to reference Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996;382(6588):250–2.PubMedCrossRef Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996;382(6588):250–2.PubMedCrossRef
23.
go back to reference Chan JL, Heist K, DePaoli AM, Veldhuis JD, Mantzoros CS. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest 2003;111(9):1409–21.PubMedCrossRef Chan JL, Heist K, DePaoli AM, Veldhuis JD, Mantzoros CS. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest 2003;111(9):1409–21.PubMedCrossRef
24.
go back to reference Chan JL, Matarese G, Shetty GK, Raciti P, Kelesidis I, Aufiero D, et al. Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans. Proc Natl Acad Sci USA 2006;103(22):8481–6.PubMedCrossRef Chan JL, Matarese G, Shetty GK, Raciti P, Kelesidis I, Aufiero D, et al. Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans. Proc Natl Acad Sci USA 2006;103(22):8481–6.PubMedCrossRef
25.
go back to reference Kalra SP, Sahu A, Kalra PS, Crowley WR. Hypothalamic neuropeptide Y: a circuit in the regulation of gonadotropin secretion and feeding behavior. Ann N Y Acad Sci 1990;611:273–83.PubMedCrossRef Kalra SP, Sahu A, Kalra PS, Crowley WR. Hypothalamic neuropeptide Y: a circuit in the regulation of gonadotropin secretion and feeding behavior. Ann N Y Acad Sci 1990;611:273–83.PubMedCrossRef
26.
go back to reference Watanobe H, Nigawara T, Anzai J, Sakihara S, Kageyama K, Nasushita R, et al. Neuropeptide Y potentiates the luteinizing hormone (LH) response to LH-releasing hormone in men. Biochem Biophys Res Commun 1994;200(2):1111–7.PubMedCrossRef Watanobe H, Nigawara T, Anzai J, Sakihara S, Kageyama K, Nasushita R, et al. Neuropeptide Y potentiates the luteinizing hormone (LH) response to LH-releasing hormone in men. Biochem Biophys Res Commun 1994;200(2):1111–7.PubMedCrossRef
27.
go back to reference Schainker BA, Cicero TJ. Acute central stimulation of luteinizing hormone by parenterally administered N-methyl-D,L-aspartic acid in the male rat. Brain Res 1980;184(2):425–37.PubMedCrossRef Schainker BA, Cicero TJ. Acute central stimulation of luteinizing hormone by parenterally administered N-methyl-D,L-aspartic acid in the male rat. Brain Res 1980;184(2):425–37.PubMedCrossRef
28.
go back to reference Medhamurthy R, Gay VL, Plant TM. Repetitive injections of L-glutamic acid, in contrast to those of N-methyl-D,L-aspartic acid, fail to elicit sustained hypothalamic GnRH release in the prepubertal male rhesus monkey (Macaca mulatta). Neuroendocrinology 1992;55(6):660–6.PubMed Medhamurthy R, Gay VL, Plant TM. Repetitive injections of L-glutamic acid, in contrast to those of N-methyl-D,L-aspartic acid, fail to elicit sustained hypothalamic GnRH release in the prepubertal male rhesus monkey (Macaca mulatta). Neuroendocrinology 1992;55(6):660–6.PubMed
29.
go back to reference van Berckel BN, Lipsch C, Gispen-de WC, Wynne HJ, Blankenstein MA, van Ree JM, et al. The partial NMDA agonist D-cycloserine stimulates LH secretion in healthy volunteers. Psychopharmacology (Berl) 1998;138(2):190–7.CrossRef van Berckel BN, Lipsch C, Gispen-de WC, Wynne HJ, Blankenstein MA, van Ree JM, et al. The partial NMDA agonist D-cycloserine stimulates LH secretion in healthy volunteers. Psychopharmacology (Berl) 1998;138(2):190–7.CrossRef
30.
go back to reference Vijayan E, McCann SM. In vivo and in vitro effects of substance P and neurotensin on gonadotropin and prolactin release. Endocrinology 1979;105(1):64–8.PubMedCrossRef Vijayan E, McCann SM. In vivo and in vitro effects of substance P and neurotensin on gonadotropin and prolactin release. Endocrinology 1979;105(1):64–8.PubMedCrossRef
31.
go back to reference Coiro V, Volpi R, Capretti L, Caiazza A, Marcato A, Bocchi R, et al. Luteinizing hormone response to an intravenous infusion of substance P in normal men. Metabolism 1992;41(7):689–91.PubMedCrossRef Coiro V, Volpi R, Capretti L, Caiazza A, Marcato A, Bocchi R, et al. Luteinizing hormone response to an intravenous infusion of substance P in normal men. Metabolism 1992;41(7):689–91.PubMedCrossRef
32.
go back to reference Horikoshi Y, Matsumoto H, Takatsu Y, Ohtaki T, Kitada C, Usuki S, et al. Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab 2003;88(2):914–9.PubMedCrossRef Horikoshi Y, Matsumoto H, Takatsu Y, Ohtaki T, Kitada C, Usuki S, et al. Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab 2003;88(2):914–9.PubMedCrossRef
33.
go back to reference Carvalho-Bianco SD, Teles M, Kuohung W, Xu S, Latronico AC, Kaiser UB. Role of GPR54 desensitization in kisspeptin action. American Endocrine Society Meeting, Boston, USA, 2006. P3–25. Carvalho-Bianco SD, Teles M, Kuohung W, Xu S, Latronico AC, Kaiser UB. Role of GPR54 desensitization in kisspeptin action. American Endocrine Society Meeting, Boston, USA, 2006. P3–25.
34.
go back to reference Panidis D, Rousso D, Koliakos G, Kourtis A, Katsikis I, Farmakiotis D, et al. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome. Fertil Steril 2006; 85(6):1778–83.PubMedCrossRef Panidis D, Rousso D, Koliakos G, Kourtis A, Katsikis I, Farmakiotis D, et al. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome. Fertil Steril 2006; 85(6):1778–83.PubMedCrossRef
35.
go back to reference Dhillo WS, Savage P, Murphy KG, Chaudhri OB, Patterson M, Nijher GM, et al. Plasma kisspeptin is raised in patients with gestational trophoblastic neoplasia and falls during treatment. Am J Physiol Endocrinol Metab 2006;291(5):E878–84.PubMedCrossRef Dhillo WS, Savage P, Murphy KG, Chaudhri OB, Patterson M, Nijher GM, et al. Plasma kisspeptin is raised in patients with gestational trophoblastic neoplasia and falls during treatment. Am J Physiol Endocrinol Metab 2006;291(5):E878–84.PubMedCrossRef
36.
go back to reference Kuohung W, Ni JJ, Mukhtyar D, Crowley WF, Glicksman MA, Kaiser UB. High throughput screening for modulators of the G protein-coupled receptor GPR54. American Endocrine Society Meeting, Boston, USA, 2006. OR25–3. Kuohung W, Ni JJ, Mukhtyar D, Crowley WF, Glicksman MA, Kaiser UB. High throughput screening for modulators of the G protein-coupled receptor GPR54. American Endocrine Society Meeting, Boston, USA, 2006. OR25–3.
37.
go back to reference Tomita K, Niida A, Oishi S, Ohno H, Cluzeau J, Navenot JM, et al. Structure-activity relationship study on small peptidic GPR54 agonists. Bioorg Med Chem 2006;14(22):7595–603.PubMedCrossRef Tomita K, Niida A, Oishi S, Ohno H, Cluzeau J, Navenot JM, et al. Structure-activity relationship study on small peptidic GPR54 agonists. Bioorg Med Chem 2006;14(22):7595–603.PubMedCrossRef
38.
go back to reference Niida A, Wang Z, Tomita K, Oishi S, Tamamura H, Otaka A, et al. Design and synthesis of downsized metastin (45–54) analogs with maintenance of high GPR54 agonistic activity. Bioorg Med Chem Lett 2006;16(1):134–7.PubMedCrossRef Niida A, Wang Z, Tomita K, Oishi S, Tamamura H, Otaka A, et al. Design and synthesis of downsized metastin (45–54) analogs with maintenance of high GPR54 agonistic activity. Bioorg Med Chem Lett 2006;16(1):134–7.PubMedCrossRef
Metadata
Title
The neuroendocrine physiology of kisspeptin in the human
Authors
Waljit S Dhillo
Kevin G Murphy
Stephen R Bloom
Publication date
01-03-2007
Published in
Reviews in Endocrine and Metabolic Disorders / Issue 1/2007
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-007-9029-1

Other articles of this Issue 1/2007

Reviews in Endocrine and Metabolic Disorders 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.